(New) Methods for Detection of <i>Aspergillus fumigatus</i> Resistance in Clinical Samples.

Loading...
Thumbnail Image

Date

2019-09

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

3
views
15
downloads

Citation Stats

Abstract

Purpose of review

The incidence of invasive aspergillosis has increased substantially over the past few decades, accompanied by a change in susceptibility patterns of Aspergillus fumigatus with increasing resistance observed against triazole antifungals, including voriconazole and isavuconazole, the most commonly used antifungal agents for the disease. Culture-based methods for determining triazole resistance are still the gold standard but are time consuming and lack sensitivity. We sought to provide an update on non-culture-based methods for detecting resistance patterns to Aspergillus.

Recent findings

New molecular-based approaches for detecting triazole resistance to Aspergillus, real-time polymerase chain reaction (PCR) to detect mutations to the Cyp51A protein, have been developed which are able to detect most triazole-resistant A. fumigatus strains in patients with invasive aspergillosis.

Summary

Over the last few years, a number of non-culture-based methods for molecular detection of Aspergillus triazole resistance have been developed that may overcome some of the limitations of culture. These molecular methods are therefore of high epidemiological and clinical relevance, mainly in immunocompromised patients with hematological malignancies, where culture has particularly limited sensitivity. These assays are now able to detect most triazole-resistant Aspergillus fumigatus strains. Given that resistance rates vary, clinical utility for these assays still depends on regional resistance patterns.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1007/s12281-019-00342-w

Publication Info

Jenks, Jeffrey D, Birgit Spiess, Dieter Buchheidt and Martin Hoenigl (2019). (New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples. Current fungal infection reports, 13(3). pp. 129–136. 10.1007/s12281-019-00342-w Retrieved from https://hdl.handle.net/10161/28642.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Jenks

Jeffrey Daniel Jenks

Adjunct Associate Professor in the Department of Medicine

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.